Objective
Antidepressant response onset is delayed in individuals with major depressive disorder (MDD). This study compared remission rates and time to remission onset for antidepressant medication delivered adjunctive to nightly time in bed (TIB) restriction of 6 hours (6h TIB) or 8 hours (8h TIB) for the initial two weeks.
Method
Sixty-eight adults with DSM-IV diagnosed MDD (25.4 ± 6.6 years of age, 34 women) were recruited from September 2009 to December 2012 in an academic medical center. Participants received 8 weeks of open-label fluoxetine 20–40 mg and were randomized to one of three TIB conditions for the first two weeks: 8h TIB (n=19); 6h TIB with a 2-hour bedtime delay (Late Bedtime, n=24); or 6h TIB with a 2-hour rise time advance (Early Risetime, n=25). Clinicians blinded to TIB condition rated symptom severity weekly. HAMD-17 rated symptom severity, remission rates, and remission onset were the primary outcomes.
Results
Mixed effects models indicated lower depression severity for the 8h TIB compared to the 6h TIB group overall (F=2.1, df=8, 226.9, p< .05), with 63.2% of 8h TIB compared to 32.6% of 6h TIB subjects remitting by Week 8 (X2(1) = 4.9, p < .05). Remission onset occurred earlier for the 8h TIB group (hazard ratio = 0.43, 95% CI 0.20 – 0.91, p < .03), with no differences between 6h TIB conditions.
Conclusions and Relevance
Two consecutive weeks of nightly 6h TIB does not accelerate or improve antidepressant response. Further research is needed to determine whether adequate sleep opportunity is important to antidepressant treatment response.